Adaptive two-stage designs in phase II clinical trials

Statistics in Medicine

Volumn 25, Issue 19, 2006, Pages 3382-3395

  Banerjee, Anindita ^a   Tsiatis, Anastasios A ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Backward induction; Bayesian decision theory; Simulated annealing; Two stage adaptive design

Indexed keywords

ARTICLE; BAYES THEOREM; CLINICAL RESEARCH; DATA ANALYSIS; DECISION MAKING; DECISION THEORY; DRUG RESEARCH; METHODOLOGY; NULL HYPOTHESIS; SAMPLE SIZE; STATISTICAL ANALYSIS;

CLINICAL TRIALS, PHASE II; CLINICAL TRIALS, PHASE II AS TOPIC; HUMANS; RESEARCH DESIGN; SAMPLE SIZE;

EID: 33749364344     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.2501     Document Type: Article

References (7)

1. Simon R. Optimal two-stage designs for phase II clinical trials. Controlled Clinical Trials 1989; 10:1-10.
2. Lai TL. Optimal stopping and sequential tests which minimize the maximum expected sample size. Annals of Statistics 1973; 1:659-673.
3. Barber S, Jennison C. Optimal asymmetric one-sided group sequential tests. Biometrika 2002; 89(1):49-60.
4. Jennison C. Efficient group sequential tests with unpredictable group sizes. Biometrika 1987; 74(1):155-165.
5. Lin DY, Geyer CJ. Computational methods for semiparametric linear regression with censored data. Journal of Computational and Graphical Statistics 1992; 1(1):77-90.
6. Piantadosi S. Clinical Trials: A Methodologic Perspective (1st edn), vol. 1. Wiley: New York, 1997.
7. Ihaka R, Gentleman R. R: a language for data analysis and graphics. Journal of Computational and Graphical Statistics 1996; 5(3):299-314.